8-38146269-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000349.3(STAR):c.465+20A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.985 in 1,614,026 control chromosomes in the GnomAD database, including 783,079 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.98 ( 72617 hom., cov: 31)
Exomes 𝑓: 0.99 ( 710462 hom. )
Consequence
STAR
NM_000349.3 intron
NM_000349.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0580
Genes affected
STAR (HGNC:11359): (steroidogenic acute regulatory protein) The protein encoded by this gene plays a key role in the acute regulation of steroid hormone synthesis by enhancing the conversion of cholesterol into pregnenolone. This protein permits the cleavage of cholesterol into pregnenolone by mediating the transport of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane. Mutations in this gene are a cause of congenital lipoid adrenal hyperplasia (CLAH), also called lipoid CAH. A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 8-38146269-T-C is Benign according to our data. Variant chr8-38146269-T-C is described in ClinVar as [Benign]. Clinvar id is 448532.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-38146269-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.984 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STAR | NM_000349.3 | c.465+20A>G | intron_variant | ENST00000276449.9 | NP_000340.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STAR | ENST00000276449.9 | c.465+20A>G | intron_variant | 1 | NM_000349.3 | ENSP00000276449.3 | ||||
STAR | ENST00000522050.1 | c.399+20A>G | intron_variant | 5 | ENSP00000429009.1 | |||||
STAR | ENST00000520114.1 | n.952+20A>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.976 AC: 148547AN: 152158Hom.: 72569 Cov.: 31
GnomAD3 genomes
AF:
AC:
148547
AN:
152158
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.981 AC: 246568AN: 251294Hom.: 121023 AF XY: 0.980 AC XY: 133121AN XY: 135830
GnomAD3 exomes
AF:
AC:
246568
AN:
251294
Hom.:
AF XY:
AC XY:
133121
AN XY:
135830
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.986 AC: 1440978AN: 1461750Hom.: 710462 Cov.: 57 AF XY: 0.985 AC XY: 716129AN XY: 727178
GnomAD4 exome
AF:
AC:
1440978
AN:
1461750
Hom.:
Cov.:
57
AF XY:
AC XY:
716129
AN XY:
727178
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.976 AC: 148652AN: 152276Hom.: 72617 Cov.: 31 AF XY: 0.976 AC XY: 72697AN XY: 74464
GnomAD4 genome
AF:
AC:
148652
AN:
152276
Hom.:
Cov.:
31
AF XY:
AC XY:
72697
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3251
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 08, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 27, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 10, 2021 | - - |
Congenital lipoid adrenal hyperplasia due to STAR deficency Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at